Intravenous Vancomycin is the Best Initial Antibiotic Choice
For this hospitalized patient with cellulitis that failed doxycycline, intravenous vancomycin 15-20 mg/kg every 8-12 hours should be initiated immediately 1, 2. The failure of doxycycline strongly suggests either MRSA infection or inadequate coverage of β-hemolytic streptococci, and vancomycin covers both possibilities while you await culture results.
Why Vancomycin is the Optimal Choice
The patient's clinical scenario—worsening cellulitis despite doxycycline requiring hospitalization—indicates this is a complicated skin and soft tissue infection (cSSTI). According to IDSA guidelines, for hospitalized patients with cSSTI, empirical MRSA coverage is recommended pending culture data 1.
Vancomycin is the parenteral drug of choice because:
- It provides bactericidal activity against both MRSA and streptococci 3
- The failure of doxycycline (which has limited activity against streptococci) suggests the pathogen may be resistant or the infection severity requires IV therapy
- It has the strongest evidence base (A-I recommendation) for hospitalized cSSTI 1
Alternative Options if Vancomycin is Contraindicated
If vancomycin cannot be used, acceptable alternatives include 1, 2:
- Linezolid 600 mg IV/PO twice daily (A-I evidence)
- Daptomycin 4 mg/kg IV once daily (A-I evidence)
- Clindamycin 600 mg IV every 8 hours (A-III evidence, but risk of inducible resistance in MRSA)
Critical Consideration: Could This Be Non-Purulent Cellulitis?
If the cellulitis is non-purulent (no drainage, no abscess), you might consider that β-hemolytic streptococci are the primary pathogen. In this scenario, the IDSA guidelines suggest a β-lactam like cefazolin 1 g IV every 8 hours could be appropriate 1, 3. However, given that doxycycline already failed and the patient requires hospitalization, I would still start with vancomycin and modify based on clinical response within 48-72 hours.
Duration and Monitoring
- Treatment duration: 7-14 days based on clinical response 1
- Assess daily for improvement: decreased erythema, reduced warmth, decreased pain
- Obtain cultures from any purulent drainage or blood cultures if systemically ill 1
- If MRSA is ruled out by culture and the patient improves, consider de-escalating to a β-lactam like cefazolin or transitioning to oral therapy
Common Pitfalls to Avoid
Do not add a β-lactam to vancomycin empirically unless you suspect necrotizing infection or have specific risk factors for gram-negative organisms (immunocompromised, diabetic foot infection, water exposure). The evidence shows monotherapy with vancomycin is sufficient for most hospitalized cellulitis cases 1, 2.
Do not continue doxycycline—it has already failed, and while it has activity against CA-MRSA, its bacteriostatic nature and limited streptococcal coverage make it inappropriate for this hospitalized patient 3, 4.
Assess for deeper infection: Since this patient failed outpatient therapy and requires hospitalization, ensure there's no underlying abscess, necrotizing fasciitis, or osteomyelitis that would require surgical intervention 1.